What we know about the Liberal-NDP pharmacare deal so farFebruary 26, 2024October 7, 2024by Nikolas Barry-ShawAnalysis
In the final days of the fight for pharmacare, will the Liberals stand up to corporate power?February 15, 2024February 16, 2024by Nikolas Barry-ShawAnalysis
Why Mexico’s 2023 ban on GM corn is the right moveJanuary 25, 2024January 26, 2024by Nikolas Barry-ShawAnalysis
Metro’s ugly move to cut off benefits shows fight for pharmacare is a working-class issueOctober 4, 2023October 4, 2023by Nikolas Barry-ShawAnalysis
Memo to the Trudeau government: Pharmacare will SAVE us a s***load (Part 1 of 2)June 21, 2023June 30, 2023by Nikolas Barry-ShawAnalysis
Protecting children’s health means investigating Big Pharma price-gougingDecember 12, 2022December 15, 2022by Nikolas Barry-ShawAnalysis
Far from a utopian idea, pharmacare is both practical and urgently neededNovember 22, 2022July 8, 2024by Nikolas Barry-ShawAnalysis
with pharmacare legislation coming, Financial post asks canadians to pity big pharma August 24, 2022June 28, 2023by Nikolas Barry-ShawAnalysis
The global fight for a People’s Vaccine is at a crucial turning pointMarch 30, 2022July 26, 2022by Nikolas Barry-ShawAnalysis
Big Pharma vs. Public Health: Why Trudeau must confront the pandemic profiteersFebruary 28, 2022July 28, 2022by Nikolas Barry-ShawAnalysis
